Drug intelligence / Profile preview

Bifidobacterium animalis subsp. lactis BLa80 + Lacticaseibacillus rhamnosus LRa05

Development stage: Unknown
Lead developer: Wecare Probiotics
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

BLa80 + LRa05 is a probiotic combination consisting of the specific bacterial strains *Bifidobacterium animalis* subsp. *lactis* BLa80 and *Lacticaseibacillus rhamnosus* LRa05. Developed by Wecare Probiotics, these strains are selected for their stability and functional properties in the gastrointestinal tract. The combination is primarily used to support gut health, modulate the intestinal microbiota, and enhance immune function. Clinical and preclinical studies have investigated these strains for their ability to inhibit pathogens, improve intestinal barrier integrity, and serve as an adjunct in the management of *Helicobacter pylori* infections.

Other names: Bifidobacterium lactis BLa80 + Lactobacillus rhamnosus LRa05BLa80 + LRa05

Beyond the preview

Go deeper on Bifidobacterium animalis subsp. lactis BLa80 + Lacticaseibacillus rhamnosus LRa05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bifidobacterium animalis subsp. lactis BLa80 + Lacticaseibacillus rhamnosus LRa05.

Explore the full profile